Rafael Palmeiro

Where do PEDs fit in the Hall of Fame debate?

26 Comments

I’m pretty sure I’ve written a post along these lines before, but a reader asked me about it in the comments to my imaginary Hall of Fame ballot post — and the issue of PEDs and the Hall of Fame are going to come up again as more and more writers reveal their 2011 ballots — so let’s go back into the breach.

The question presented: why did I not include Rafael Palmiero in my imaginary Hall of Fame ballot.  Was it the PED association or was it a performance-based thing?  The answer: Both. As in, I see the issues as intertwined.

My take on PEDs has long been that they should not automatically disqualify a player from Hall of Fame consideration. We don’t know for sure who did them and who didn’t. For those whom we know did them, we don’t know when they started, when they stopped, how much juice they took or what kind of juice it was.  We don’t know whether the hitters or the pitchers were aided more by it. We can’t ignore all of the numbers posted by PED-associated ballplayer because there are other factors in play — ballpark size, strike zone, etc. — that affect them.

So what do we do with guys like Palmiero? My best answer so far — and if you have a better one, I’m open to it — is to determine whether, roughly speaking, we think the guy was a Hall of Famer even if he never used PEDs. Yes, I know that invites its own form of chaos, but I see it preferable to either assuming his entire record was fraudulent or assuming that PEDs had zero impact because we know neither of those things is the case. Put differently: uncertainty is preferable to being certainly wrong.

I look at Palmeiro and I see a guy who was very good for a very long time in some very friendly hitters parks while playing a good bit of DH. I see a guy who, while crossing over the magic 500 home run and 3000 hit barrier, was never considered the absolute best hitter in the league. And then I have to take a couple of mental ticks off because of the PED association.

Putting those things together, I think he’s a close call. I may change my mind on him one day. But he’ll be eligible for a long time yet. In that time, we may come to learn more about his own history of PED use and the history of PED use in baseball in general. That information may make Palmeiro rise in my estimation. It may make him sink. But I feel like I need to take that time in his case due to that uncertainty.  If our information on Palmiero and PEDs in general remained static for the entire time Palmiero was on the ballot, I’d probably err on the side of not voting for him.

In contrast, I don’t believe that Mark McGwire is as close a call under such an analysis, though I think reasonable people can disagree about him.  I certainly don’t think that Barry Bonds or Roger Clemens is a close call given that they’re so far beyond worthy of election based on their performance that even the most harsh PED-discount would drag them below the line.  The only people who should be voting against them are the hardliners who think no PED-user should ever be elected, and like I said, I’m not one of those.

Palmiero may be as close as we get. Kevin Brown is in that boat as well.  Either way, they’re tough cases. Abd if I had the franchise, I’d hold off on them for a bit.

 

Danny Espinosa reportedly skipped Nationals Winterfest because of Adam Eaton

WASHINGTON, DC - OCTOBER 13: Danny Espinosa #8 of the Washington Nationals celebrates after teammate Chris Heisey #14 (not pictured) hits a two run home run in the seventh inning against the Los Angeles Dodgers during game five of the National League Division Series at Nationals Park on October 13, 2016 in Washington, DC. (Photo by Rob Carr/Getty Images)
Getty Images
8 Comments

According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.

A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.

Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.

Espinosa will reach free agency after the 2017 season.

Nick Cafardo: Red Sox should deal Pomeranz, not Buchholz

BOSTON, MA - SEPTEMBER 18: Drew Pomeranz #31 of the Boston Red Sox pitches during the first inning against the New York Yankees at Fenway Park on September 18, 2016 in Boston, Massachusetts. The Red Sox won 5-4. (Photo by Rich Gagnon/Getty Images)
Getty Images
11 Comments

The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.

The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.

Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.

Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.